AMRN 13F Hedge Fund and Asset Management Owners

Data as of 2020-10-17
Market Cap	2.002 Billion	Shares Outstanding	388.673 Million	Avg 30-day Volume	8.648 Million
P/E Ratio		Dividend Yield		EPS	-0.06
Price/Sales	4.634	Price cash flow ratio	101.0	Price free cash flow ratio	-522.0
Book Value	1.53	Price to Tangible Book	3.44	Alpha	0.05
Short Interest Ratio		% Short Interest to Float		R-squared	0.043824
BETA	2.8066	52-week High/Low	26.12 / 3.36	Stddev	0.575775

Q2 2020	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change
In top 10:	5	3	66.67%	3 (0.2%)	3 (0.19%)	0.0%
Funds Holding:	274	299	-8.36%	74 (4.83%)	80 (5.12%)	-7.5%
13F shares:	161.832 Million	169.703 Million	-4.64%	105.099 Million	112.334 Million	-6.44%
% Ownership	41.6369	46.9828	-11.38%	27.0404	31.1002	-13.05%
New Positions:	49	51	-3.92%	20	15	33.33%
Increased Positions	92	114	-19.3%	21	30	-30.0%
Closed Positions	68	68	0.0%	25	20	25.0%
Reduced Positions	60	80	-25.0%	19	25	-24.0%
Total Calls	9.103 Million	28.284 Million	-67.82%	2.441 Million	7.843 Million	-68.87%
Total Puts	9.096 Million	10.856 Million	-16.22%	2.246 Million	2.28 Million	-1.51%
PUT/CALL Ratio	1.0	0.38	163.16%	0.92	0.29	217.24%
¹ hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding AMRN (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Market Value:

Ranking:

% of portfolio

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AMRN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

52.5 Thousand total shares from 20 transactions

Current/Former Insiders

Insider Name	Type	Last Reported Shares Held	Last Reported Date	Filings in past year
KENNEDY JOSEPH T GENERAL COUNSEL		209,269	2020-09-30	10
THERO JOHN F PRESIDENT AND CEO		2,542,933	2020-09-30	14
KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER		526,854	2020-09-30	10
KALB MICHAEL WAYNE SVP AND CFO		96,913	2020-09-30	11
BERG AARON CHIEF COMMERCIAL OFFICER		212,942	2020-09-30	11
VAN HEEK G JAN		0	2020-07-13	1
ZAKRZEWSKI JOSEPH S		0	2020-07-13	3
O'SULLIVAN PATRICK J		0	2020-07-13	1
EKMAN LARS		0	2020-07-13	3
PETERSON KRISTINE		0	2020-07-13	1
STACK DAVID M		0	2020-07-13	1
SALYER MARK CHIEF COMMERCIAL OFFICER	Officer	0	2018-02-01	0
HEALY JAMES	Director	0	2016-07-11	0
FARRELL MICHAEL JAMES VP, FINANCE	Officer	30,190	2016-01-31	0
ORBIMED ADVISORS LLC ORBIMED CAPITAL GP III LLC ISALY SAMUEL D	Director	600,000	2012-09-04	0
GORDON CARL L	Director	600,000	2012-09-04	0
SEDLACK STUART D SENIOR VICE PRESIDENT	Officer	0	2012-07-26	0
HUFF PAUL CHIEF COMMERCIAL OFFICER	Officer	0	2012-07-26	0
ANDERSON JOSEPH	Director	0	2012-07-10	0
ABINGWORTH LLP	10% Owner	No longer subject to file	2012-04-17	0
AHLHOLM FREDERICK W VICE PRESIDENT FINANCE	Officer	0	2012-02-01	0
SONI PARESH SVP AND HEAD OF DEVELOPMENT	Officer	0	2012-02-01	0
FOUNTAIN HEALTHCARE PARTNERS LTD.	Director	2,517,391	2011-09-30	0
FEIGAL DAVID W JR	Director	0	2011-07-12	0
SOFINNOVA VENTURE PARTNERS VII L P SOFINNOVA MANAGEMENT VII, L.L.C. HEALY JAMES POWELL MICHAEL BUATOIS ERIC	Director 10% Owner	8,513,388	2011-03-29	0
ROGAN MANUS	Director	17,391	2011-01-01	0

Insider Transactions Last 60 Days

Reporting Owners	Filing Date	Trans Date	Trans Code	Shares	Share Price	Acquired Disposed	Shares Owned after	D/I	Perf 1d*	Perf 5d*	Perf 1m*	Max Gain	Max Gain Days	Max Loss	Max Loss Days
KALB MICHAEL WAYNE SVP AND CFO	2020-10-02 20:05:04 -0400	2020-09-30	M	1,528		d	16,805	direct
BERG AARON CHIEF COMMERCIAL OFFICER	2020-10-02 20:05:39 -0400	2020-09-30	M	1,528		d	16,805	direct
BERG AARON CHIEF COMMERCIAL OFFICER	2020-10-02 20:05:39 -0400	2020-09-30	M	1,528		a	214,448	direct	-1.581	1.581		4.9407	3	-1.581	2
THERO JOHN F PRESIDENT AND CEO	2020-10-02 20:03:08 -0400	2020-09-30	M	6,737		d	74,096	direct
THERO JOHN F PRESIDENT AND CEO	2020-10-02 20:03:08 -0400	2020-09-30	M	6,737		a	2,536,196	direct	-1.581	1.581		4.9407	3	-1.581	2
KENNEDY JOSEPH T GENERAL COUNSEL	2020-10-02 20:03:51 -0400	2020-09-30	M	1,806		a	209,269	direct	-1.581	1.581		4.9407	3	-1.581	2
KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER	2020-10-02 20:04:26 -0400	2020-09-30	M	1,528		d	16,805	direct
KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER	2020-10-02 20:04:26 -0400	2020-09-30	M	1,528		a	526,832	direct	-1.581	1.581		4.9407	3	-1.581	2
KALB MICHAEL WAYNE SVP AND CFO	2020-10-02 20:05:04 -0400	2020-09-30	M	1,528		a	96,913	direct	-1.581	1.581		4.9407	3	-1.581	2
BERG AARON CHIEF COMMERCIAL OFFICER	2020-10-02 20:05:39 -0400	2020-09-30	M	1,528		d	16,805	direct
BERG AARON CHIEF COMMERCIAL OFFICER	2020-10-02 20:05:39 -0400	2020-09-30	M	1,528		a	212,920	direct	-1.581	1.581		4.9407	3	-1.581	2
THERO JOHN F PRESIDENT AND CEO	2020-10-02 20:03:08 -0400	2020-09-30	M	6,737		d	74,096	direct
KENNEDY JOSEPH T GENERAL COUNSEL	2020-10-02 20:03:51 -0400	2020-09-30	M	1,806		d	19,860	direct
KENNEDY JOSEPH T GENERAL COUNSEL	2020-10-02 20:03:51 -0400	2020-09-30	M	1,806		a	207,463	direct	-1.581	1.581		4.9407	3	-1.581	2
KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER	2020-10-02 20:04:26 -0400	2020-09-30	F	1,506	$4.04	d	526,854	direct	-1.581	1.581		4.9407	3	-1.581	2
KALB MICHAEL WAYNE SVP AND CFO	2020-10-02 20:05:04 -0400	2020-09-30	M	1,528		d	16,805	direct
KALB MICHAEL WAYNE SVP AND CFO	2020-10-02 20:05:04 -0400	2020-09-30	M	1,528		a	95,385	direct	-1.581	1.581		4.9407	3	-1.581	2
BERG AARON CHIEF COMMERCIAL OFFICER	2020-10-02 20:05:39 -0400	2020-09-30	F	1,506	$4.04	d	212,942	direct	-1.581	1.581		4.9407	3	-1.581	2
THERO JOHN F PRESIDENT AND CEO	2020-10-02 20:03:08 -0400	2020-09-30	M	6,737		a	2,542,933	direct	-1.581	1.581		4.9407	3	-1.581	2
KENNEDY JOSEPH T GENERAL COUNSEL	2020-10-02 20:03:51 -0400	2020-09-30	M	1,806		d	19,860	direct
KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER	2020-10-02 20:04:26 -0400	2020-09-30	M	1,528		d	16,805	direct
KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER	2020-10-02 20:04:26 -0400	2020-09-30	M	1,528		a	528,360	direct	-1.581	1.581		4.9407	3	-1.581	2
BERG AARON CHIEF COMMERCIAL OFFICER	2020-09-02 20:07:37 -0400	2020-08-31	M	1,527		a	211,371	direct	-5.7018	-10.5263	12.9386	16.4474	24	-20.1754	15
THERO JOHN F PRESIDENT AND CEO	2020-09-02 20:01:43 -0400	2020-08-31	M	6,736		d	80,833	direct
THERO JOHN F PRESIDENT AND CEO	2020-09-02 20:01:43 -0400	2020-08-31	M	6,736		a	2,528,025	direct	-5.7018	-10.5263	12.9386	16.4474	24	-20.1754	15
KENNEDY JOSEPH T GENERAL COUNSEL	2020-09-02 20:02:16 -0400	2020-08-31	F	1,902	$7.36	d	205,657	direct	-5.7018	-10.5263	12.9386	16.4474	24	-20.1754	15
KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER	2020-09-02 20:04:53 -0400	2020-08-31	M	1,527		d	18,333	direct
KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER	2020-09-02 20:04:53 -0400	2020-08-31	M	1,527		a	526,810	direct	-5.7018	-10.5263	12.9386	16.4474	24	-20.1754	15
KALB MICHAEL WAYNE SVP AND CFO	2020-09-02 20:06:59 -0400	2020-08-31	M	1,527		d	18,333	direct
KALB MICHAEL WAYNE SVP AND CFO	2020-09-02 20:06:59 -0400	2020-08-31	M	1,527		a	93,826	direct	-5.7018	-10.5263	12.9386	16.4474	24	-20.1754	15
BERG AARON CHIEF COMMERCIAL OFFICER	2020-09-02 20:07:37 -0400	2020-08-31	F	1,506	$7.36	d	211,392	direct	-5.7018	-10.5263	12.9386	16.4474	24	-20.1754	15
THERO JOHN F PRESIDENT AND CEO	2020-09-02 20:01:43 -0400	2020-08-31	F	5,302	$7.36	d	2,529,459	direct	-5.7018	-10.5263	12.9386	16.4474	24	-20.1754	15
KENNEDY JOSEPH T GENERAL COUNSEL	2020-09-02 20:02:16 -0400	2020-08-31	M	1,805		d	21,666	direct
KENNEDY JOSEPH T GENERAL COUNSEL	2020-09-02 20:02:16 -0400	2020-08-31	M	1,805		a	207,559	direct	-5.7018	-10.5263	12.9386	16.4474	24	-20.1754	15
KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER	2020-09-02 20:04:53 -0400	2020-08-31	M	1,527		d	18,333	direct
KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER	2020-09-02 20:04:53 -0400	2020-08-31	M	1,527		a	525,283	direct	-5.7018	-10.5263	12.9386	16.4474	24	-20.1754	15
KALB MICHAEL WAYNE SVP AND CFO	2020-09-02 20:06:59 -0400	2020-08-31	F	1,496	$7.36	d	93,857	direct	-5.7018	-10.5263	12.9386	16.4474	24	-20.1754	15
BERG AARON CHIEF COMMERCIAL OFFICER	2020-09-02 20:07:37 -0400	2020-08-31	M	1,527		d	18,333	direct
BERG AARON CHIEF COMMERCIAL OFFICER	2020-09-02 20:07:37 -0400	2020-08-31	M	1,527		a	212,898	direct	-5.7018	-10.5263	12.9386	16.4474	24	-20.1754	15
THERO JOHN F PRESIDENT AND CEO	2020-09-02 20:01:43 -0400	2020-08-31	M	6,736		d	80,833	direct
THERO JOHN F PRESIDENT AND CEO	2020-09-02 20:01:43 -0400	2020-08-31	M	6,736		a	2,534,761	direct	-5.7018	-10.5263	12.9386	16.4474	24	-20.1754	15
KENNEDY JOSEPH T GENERAL COUNSEL	2020-09-02 20:02:16 -0400	2020-08-31	M	1,805		d	21,666	direct
KENNEDY JOSEPH T GENERAL COUNSEL	2020-09-02 20:02:16 -0400	2020-08-31	M	1,805		a	205,754	direct	-5.7018	-10.5263	12.9386	16.4474	24	-20.1754	15
KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER	2020-09-02 20:04:53 -0400	2020-08-31	F	1,506	$7.36	d	525,304	direct	-5.7018	-10.5263	12.9386	16.4474	24	-20.1754	15
KALB MICHAEL WAYNE SVP AND CFO	2020-09-02 20:06:59 -0400	2020-08-31	M	1,527		d	18,333	direct
KALB MICHAEL WAYNE SVP AND CFO	2020-09-02 20:06:59 -0400	2020-08-31	M	1,527		a	95,353	direct	-5.7018	-10.5263	12.9386	16.4474	24	-20.1754	15
BERG AARON CHIEF COMMERCIAL OFFICER	2020-09-02 20:07:37 -0400	2020-08-31	M	1,527		d	18,333	direct

* -

Transaction Code Definitions
Code	Definition
A	Grant, award or other acquisition pursuant to Rule 16b-3(d)
C	Conversion of derivative security
D	Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E	Expiration of short derivative position
F	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G	Bona fide gift
H	Expiration (or cancellation) of long derivative position with value received
I	Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J	Other acquisition or disposition
L	Small acquisition under Rule 16a-6
M	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O	Exercise of out-of-the-money derivative security
P	Open market or private purchase of non-derivative or derivative security
S	Open market or private sale of non-derivative or derivative security
U	Disposition pursuant to a tender of shares in a change of control transaction
W	Acquisition or disposition by will or the laws of descent and distribution
X	Exercise of in-the-money or at-the-money derivative security
Z	Deposit into or withdrawal from voting trust

Amarin Corp. ADR Chart by YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Amarin Corp. ADR (AMRN)

WhaleWisdom Alpha

Our Other Reporting & Analysis